As shown in Fig. 7d, e, tumors from X-LAG syndrome cases exhibited markedly elevated phospho-PKC staining, as compared to the low level seen in acromegaly controls, including tumors from patients with aryl hydrocarbon receptor interacting protein (AIP) mutations, an aggressive, treatment-resistant genetic form of acrogigantism. This evidence concerns the gene PRRT2 and acromegaly.